OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Matthew Disney

1 Projects | 1 Researchers | $150,000 Invested

2014

The Scripps Research Institute

Matthew Disney, PhD

Lead optimization and pre-clinical testing of small molecules that modulate toxicity of cFTD/ALS"

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Other
  • Status: Closed